EX-99.1 2 v387283_ex99-1.htm EARNINGS RELEASE

 

Exhibit 99.1

 

MGT Reports 2014 Second Quarter Results

DraftDay.com Powers Sequential Gross Margin Growth of 430% on Record Revenues

 

Harrison, NY (August 14, 2014) – MGT Capital Investments, Inc. (NYSE MKT: MGT) today reported financial results and operational developments for the fiscal second quarter ended June 30, 2014. Developments during the quarter and recent weeks subsequent to quarter end are as follows:

 

·Acquired www.DraftDay.com and MGT has become the number 3 participant (based on player activity, guaranteed contest sizes, and similar metrics) in the rapidly growing daily fantasy sports industry.
·Officially launched www.mgtplay.com, a proprietary real money skill-based gaming website.
·Strategically decided to focus resources and litigation efforts against Aruze Gaming in patent assertion efforts and have dismissed lawsuits against WMS Gaming Inc. In addition, MGT and WMS filed a joint motion to terminate the Inter Partes Review (IPR) with the United States Patent Trial and Appeal Board.
·MGT Sports formally launched the white label version of its daily fantasy sports platform with www.VegasInsider.com.
·MGT Sports launched the online informational portal, www.FantasySportsLive.com, which provides leading news, podcasts, video, strategy and commentary for the daily fantasy sports industry.

 

Robert Ladd, MGT’s Chief Executive Officer commented, “Through careful acquisitions and development, we have transformed MGT into a leading skill based gaming company; as we continue to execute, we are confident that shareholders will benefit greatly.”

 

“Q2 was highlighted by our acquisition of DraftDay.com. We anticipate major increases in user growth and player activity on our websites fueled by the upcoming professional football season, mobile app launch and our white–label partnerships,” Ladd stated.

 

Financial Results

 

For the second quarter ended June 30, 2014, total revenue was $320,000, as compared to $67,000 for the same period last year. Gross margin totaled $153,000 (48% of revenue) up from $47,000 in the second quarter of 2013. Operating expenses decreased by approximately 47% to $1.7 million from $3.1 million for the same period in 2013. The decrease is primarily due to lower stock–based compensation expense, professional fees and corporate governance related costs. Operating loss was $1.5 million during the second quarter, compared to a loss of $3.1 million in the same period of 2013.

 

For the six months ended June 30, 2014, total revenue was $405,000, as compared with $153,000 for the same period in 2013. Gross margin totaled $189,000 up from $70,000 in the second quarter of 2013. Operating expenses decreased by approximately 30% to $3 million from $4.3 million for the first half of 2013. The operating loss for the first six months of 2014 was $2.8 million as compared with $4.2 million loss for the same period last year.

 

Cash and cash equivalents as of June 30, 2014 were $2.4 million. During the quarter, net cash used in operating activities was $1.0 million (exclusive of changes in player funds), as compared to $1.1 million in the comparable period of 2013. The company expects cash utilization to be significantly lower for the remainder of 2014, due to the positive contribution from gross margin of MGT Sports.

 

 
 

 

About MGT Capital Investments, Inc.

 

MGT Capital and its subsidiaries operate social and real money gaming sites online and in the mobile space, including ownership of the 3rd largest daily fantasy sports wagering platform, www.DraftDay.com. The Company also offers games of skill through www.MGTplay.com and social casino games with SlotChamp™, and has created an online portal for fantasy sports news and commentary, www.FantasySportsLive.com. In addition, the Company owns intellectual property relating to slot machines and has asserted its claims via patent infringement lawsuits.

 

Forward-looking Statements

 

This press release contains forward-looking statements. The words or phrases “would be,” “will allow,” “intends to,” “will likely result,” “are expected to,” “will continue,” “is anticipated,” “estimate,” “project,” or similar expressions are intended to identify “forward-looking statements.” MGT’s financial and operational results reflected above should not be construed by any means as representative of the current or future value of its common stock. All information set forth in this news release, except historical and factual information, represents forward-looking statements. This includes all statements about the Company’s plans, beliefs, estimates and expectations. These statements are based on current estimates and projections, which involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. These risks and uncertainties include issues related to: rapidly changing technology and evolving standards in the industries in which the Company and its subsidiaries operate; the ability to obtain sufficient funding to continue operations, maintain adequate cash flow, profitably exploit new business, license and sign new agreements; the unpredictable nature of consumer preferences; and other factors set forth in the Company’s most recently filed annual report and registration statement. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management’s analysis only as of the date hereof. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof. Readers should carefully review the risks and uncertainties described in other documents that the Company files from time to time with the U.S. Securities and Exchange Commission.

 

 

Company Contact

 

MGT Capital Investments, Inc.

Robert Traversa, Chief Financial Officer

914-630-7431

rtraversa@mgtci.com

 

 
 

 

MGT CAPITAL INVESTMENTS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except share and per–share amounts)

 

   June 30,   December 31, 
   2014   2013 
   (Unaudited)     
Assets:          
Current assets:          
Cash and cash equivalents  $2,425   $4,642 
Accounts receivable   46    43 
Prepaid expenses and other current assets   182    132 
Total current assets   2,653    4,817 
           
Non–current assets:          
Restricted cash   138    140 
Property and equipment, at cost, net   48    45 
Intangible assets, net   2,913    2,423 
Goodwill   6,444    6,444 
Other non–current assets   4    4 
Total assets  $12,200   $13,873 
           
Liabilities:          
Current liabilities:          
Accounts payable  $435   $228 
Accrued expenses   86    94 
Player deposit liability   788    647 
Other payables   36    16 
Total current liabilities   1,345    985 
           
Total liabilities   1,345    985 
           
Commitments and contingencies:          
Redeemable convertible preferred stock – Temporary equity:          
Preferred stock, series A convertible preferred, $0.001 par value; 1,416,160 and 1,416,160 shares authorized at June 30, 2014 and December 31, 2013, respectively; 9,699 and 9,413 shares issued and outstanding at June 30, 2014 and December 31, 2013, respectively        
Stockholders’ equity/(deficit):          
Undesignated preferred stock, $0.001 par value; 8,583,840 and 8,583,840 shares authorized at June 30, 2014 and December 31, 2013, respectively. No shares authorized, issued and outstanding at June 30, 2014 and December 31, 2013 respectively        
Common Stock, $0.001 par value; 75,000,000 shares authorized; 9,361,453 and 8,848,686 shares issued and outstanding at June 30, 2014 and December 31, 2013, respectively   9    9 
Additional paid–in capital   305,935    304,886 
Accumulated other comprehensive loss   (281)   (281)
Accumulated deficit   (296,346)   (293,833)
Total stockholders’ equity   9,317    10,781 
Non–controlling interests   1,538    2,107 
Total equity   10,855    12,888 
           
Total stockholders’ equity, liabilities and non–controlling interest  $12,200   $13,873 

 

 
 

 

MGT CAPITAL INVESTMENTS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except share and per–share amounts)
(Unaudited)

 

   Three months ended June 30, 
   2014   2013 
Revenues:          
Software and devices  $37   $27 
Services – Consulting       22 
Gaming   276    18 
Other   7     
    320    67 
Cost of revenues:          
Gaming   167    20 
    167    20 
           
Gross margin   153    47 
           
Operating expenses:          
General and administrative   1,536    3,078 
Sales and marketing   91    66 
Research and development   53     
    1,680    3,144 
           
Operating loss   (1,527)   (3,097)
           
Other non–operating income:          
Interest and other income   2    3 
Gain on sale of medical imagine patents       750 
Change in fair value of warrants       (4,326)
    2    (3,573)
           
Net loss before income taxes and non–controlling interest   (1,525)   (6,670)
           
Income tax (expense) / benefit   1     
           
Net loss before non–controlling interest   (1,524)   (6,670)
           
Net loss attributable to non–controlling interest   133    91 
           
Net loss attributable to MGT Capital Investments, Inc.  $(1,391)  $(6,579)
           
Less:          
Quarterly dividend on Preferred Series A Stock       (7)
Net loss applicable to Common shareholders  $(1,391)  $(6,586)
           
Per–share data:          
Basic and diluted loss per share  $(0.15)  $(1.38)
           
Weighted average number of common shares outstanding   9,057,867    4,766,904 

 

 
 

 

MGT CAPITAL INVESTMENTS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except share and per–share amounts)
(Unaudited)

 

   Six months ended June 30, 
   2014   2013 
Revenues:          
Software and devices  $80   $38 
Services – Consulting       97 
Gaming   318    18 
Other   7     
    405    153 
Cost of revenues:          
Services – Consulting       63 
Gaming   216    20 
    216    83 
           
Gross margin   189    70 
           
Operating expenses:          
General and administrative   2,800    4,239 
Sales and marketing   108    66 
Research and development   113     
    3,021    4,305 
           
Operating loss   (2,832)   (4,235)
           
Other non–operating income:          
Interest and other income   5    27 
Gain on sale of medical imagine patents       750 
Change in fair value of warrants       (2,204)
    5    (1,427)
           
Net loss before income taxes and non–controlling interest   (2,827)   (5,662)
           
Income tax benefit / (expense)   11    (3)
           
Net loss before non–controlling interest   (2,816)   (5,665)
           
Net loss attributable to non–controlling interest   303    147 
           
Net loss income attributable to MGT  $(2,513)  $(5,518)
           
Less:          
Quarterly dividend on Series A Preferred Stock       (68)
Net loss applicable to Common shareholders  $(2,513)  $(5,586)
           
Per–share data:          
Basic and diluted loss per share  $(0.28)  $(1.02)
           
Weighted average number of common shares outstanding   8,921,935    5,472,423